Delivery Order SPE2DB20D3505-SPE2DB20FT3A4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through December 31, 2025. The contract serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The contract is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. It serves as the primary vehicle for Amerisourcebergen to deliver specialty,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00, runs through November 2026 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers a wide array...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense (DoD) worldwide. The contract, valued at up to $999,999,999.00, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver specialty, brand name, generic, and...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The Indefinite Delivery Contract (IDC), valued up to $999,999,999.00 through December 31, 2025, is the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This includes specialty,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, awarded by the Defense Logistics Agency (DLA), is a $999,999,999.00 Indefinite Delivery Contract (IDC) that runs through November 2026. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides pharmaceutical products and medical supplies to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical and medical commodities, including specialty...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for Amerisourcebergen to deliver specialty, brand name,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB20FT3A4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) and other federal healthcare programs globally. The contract covers essential medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen, through its parent company Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.4k | 9/16/20 |